Back to Search
Start Over
Patient With Stage IV NSCLC and CNS Metastasis With EGFR Exon 18-25 Kinase Domain Duplication With Response to Osimertinib as a First-Line Therapy
- Source :
- JCO Precision Oncology. :88-92
- Publication Year :
- 2021
- Publisher :
- American Society of Clinical Oncology (ASCO), 2021.
- Subjects :
- Male
Cancer Research
Lung Neoplasms
Central Nervous System Neoplasms
Exon
First line therapy
Carcinoma, Non-Small-Cell Lung
Gene duplication
Humans
Medicine
Osimertinib
Neoplasm Metastasis
Protein Kinase Inhibitors
Neoplasm Staging
Acrylamides
Aniline Compounds
business.industry
Exons
Middle Aged
Magnetic Resonance Imaging
ErbB Receptors
Oncology
Protein kinase domain
CNS metastasis
Cancer research
Tomography, X-Ray Computed
business
Stage iv
Subjects
Details
- ISSN :
- 24734284
- Database :
- OpenAIRE
- Journal :
- JCO Precision Oncology
- Accession number :
- edsair.doi.dedup.....36b0ab474c5aee7fe26c7ff95f2c20f3